vs

Side-by-side financial comparison of A10 Networks, Inc. (ATEN) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

Schrodinger, Inc. is the larger business by last-quarter revenue ($87.2M vs $75.0M, roughly 1.2× A10 Networks, Inc.). Schrodinger, Inc. runs the higher net margin — 37.3% vs 16.0%, a 21.2% gap on every dollar of revenue. On growth, A10 Networks, Inc. posted the faster year-over-year revenue change (13.4% vs -1.2%). Over the past eight quarters, Schrodinger, Inc.'s revenue compounded faster (54.4% CAGR vs 11.7%).

A10 Networks, Inc. is an American public company specializing in the manufacturing of application delivery controllers. Founded in 2004 by Lee Chen, co-founder of Foundry Networks, A10 originally serviced just the identity management market with its line of ID Series products. In early 2007, they added bandwidth management appliances. The company had its initial public offering on March 21, 2014, raising $187.5 million.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

ATEN vs SDGR — Head-to-Head

Bigger by revenue
SDGR
SDGR
1.2× larger
SDGR
$87.2M
$75.0M
ATEN
Growing faster (revenue YoY)
ATEN
ATEN
+14.6% gap
ATEN
13.4%
-1.2%
SDGR
Higher net margin
SDGR
SDGR
21.2% more per $
SDGR
37.3%
16.0%
ATEN
Faster 2-yr revenue CAGR
SDGR
SDGR
Annualised
SDGR
54.4%
11.7%
ATEN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ATEN
ATEN
SDGR
SDGR
Revenue
$75.0M
$87.2M
Net Profit
$12.0M
$32.5M
Gross Margin
79.6%
65.7%
Operating Margin
17.3%
-19.7%
Net Margin
16.0%
37.3%
Revenue YoY
13.4%
-1.2%
Net Profit YoY
26.1%
180.8%
EPS (diluted)
$0.17
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATEN
ATEN
SDGR
SDGR
Q1 26
$75.0M
Q4 25
$80.4M
$87.2M
Q3 25
$74.7M
$54.3M
Q2 25
$69.4M
$54.8M
Q1 25
$66.1M
$59.6M
Q4 24
$74.2M
$88.3M
Q3 24
$66.7M
$35.3M
Q2 24
$60.1M
$47.3M
Net Profit
ATEN
ATEN
SDGR
SDGR
Q1 26
$12.0M
Q4 25
$9.9M
$32.5M
Q3 25
$12.2M
$-32.8M
Q2 25
$10.5M
$-43.2M
Q1 25
$9.5M
$-59.8M
Q4 24
$18.3M
$-40.2M
Q3 24
$12.6M
$-38.1M
Q2 24
$9.5M
$-54.0M
Gross Margin
ATEN
ATEN
SDGR
SDGR
Q1 26
79.6%
Q4 25
78.7%
65.7%
Q3 25
80.1%
51.6%
Q2 25
78.9%
47.8%
Q1 25
79.7%
52.3%
Q4 24
79.9%
72.6%
Q3 24
80.5%
50.2%
Q2 24
80.0%
66.2%
Operating Margin
ATEN
ATEN
SDGR
SDGR
Q1 26
17.3%
Q4 25
18.7%
-19.7%
Q3 25
17.4%
-84.6%
Q2 25
14.9%
-96.6%
Q1 25
13.3%
-85.5%
Q4 24
24.8%
-23.5%
Q3 24
15.7%
-193.9%
Q2 24
13.2%
-111.4%
Net Margin
ATEN
ATEN
SDGR
SDGR
Q1 26
16.0%
Q4 25
12.3%
37.3%
Q3 25
16.3%
-60.4%
Q2 25
15.2%
-78.8%
Q1 25
14.4%
-100.4%
Q4 24
24.7%
-45.5%
Q3 24
18.9%
-108.1%
Q2 24
15.8%
-114.2%
EPS (diluted)
ATEN
ATEN
SDGR
SDGR
Q1 26
$0.17
Q4 25
$0.13
$0.45
Q3 25
$0.17
$-0.45
Q2 25
$0.14
$-0.59
Q1 25
$0.13
$-0.82
Q4 24
$0.24
$-0.55
Q3 24
$0.17
$-0.52
Q2 24
$0.13
$-0.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATEN
ATEN
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$57.9M
$395.5M
Total DebtLower is stronger
$219.2M
Stockholders' EquityBook value
$220.8M
$364.1M
Total Assets
$634.4M
$726.2M
Debt / EquityLower = less leverage
0.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATEN
ATEN
SDGR
SDGR
Q1 26
$57.9M
Q4 25
$684.6M
$395.5M
Q3 25
$370.9M
$391.2M
Q2 25
$367.4M
$450.2M
Q1 25
$355.8M
$500.3M
Q4 24
$195.6M
$352.1M
Q3 24
$182.1M
$388.7M
Q2 24
$177.1M
$377.3M
Total Debt
ATEN
ATEN
SDGR
SDGR
Q1 26
$219.2M
Q4 25
$218.8M
Q3 25
$218.4M
Q2 25
$218.1M
Q1 25
$217.7M
Q4 24
$0
Q3 24
Q2 24
Stockholders' Equity
ATEN
ATEN
SDGR
SDGR
Q1 26
$220.8M
Q4 25
$211.5M
$364.1M
Q3 25
$206.2M
$321.4M
Q2 25
$204.0M
$342.9M
Q1 25
$195.9M
$373.5M
Q4 24
$231.8M
$421.4M
Q3 24
$217.3M
$449.4M
Q2 24
$214.4M
$474.0M
Total Assets
ATEN
ATEN
SDGR
SDGR
Q1 26
$634.4M
Q4 25
$629.8M
$726.2M
Q3 25
$620.1M
$653.7M
Q2 25
$607.9M
$688.2M
Q1 25
$606.2M
$743.0M
Q4 24
$432.8M
$823.2M
Q3 24
$407.7M
$669.3M
Q2 24
$397.2M
$688.4M
Debt / Equity
ATEN
ATEN
SDGR
SDGR
Q1 26
0.99×
Q4 25
1.03×
Q3 25
1.06×
Q2 25
1.07×
Q1 25
1.11×
Q4 24
0.00×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATEN
ATEN
SDGR
SDGR
Operating Cash FlowLast quarter
$2.2M
$-16.1M
Free Cash FlowOCF − Capex
$-16.1M
FCF MarginFCF / Revenue
-18.5%
Capex IntensityCapex / Revenue
3.9%
0.0%
Cash ConversionOCF / Net Profit
0.19×
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATEN
ATEN
SDGR
SDGR
Q1 26
$2.2M
Q4 25
$22.7M
$-16.1M
Q3 25
$22.8M
$-61.9M
Q2 25
$22.2M
$-52.2M
Q1 25
$17.2M
$144.1M
Q4 24
$25.7M
$-31.1M
Q3 24
$20.1M
$-33.3M
Q2 24
$12.2M
$-53.7M
Free Cash Flow
ATEN
ATEN
SDGR
SDGR
Q1 26
Q4 25
$16.0M
$-16.1M
Q3 25
$18.1M
$-62.4M
Q2 25
$17.9M
$-52.5M
Q1 25
$12.7M
$143.5M
Q4 24
$23.3M
$-32.0M
Q3 24
$16.7M
$-34.6M
Q2 24
$8.7M
$-54.7M
FCF Margin
ATEN
ATEN
SDGR
SDGR
Q1 26
Q4 25
20.0%
-18.5%
Q3 25
24.2%
-114.8%
Q2 25
25.9%
-95.9%
Q1 25
19.2%
240.9%
Q4 24
31.4%
-36.2%
Q3 24
25.0%
-98.0%
Q2 24
14.5%
-115.6%
Capex Intensity
ATEN
ATEN
SDGR
SDGR
Q1 26
3.9%
Q4 25
8.3%
0.0%
Q3 25
6.3%
0.9%
Q2 25
6.1%
0.6%
Q1 25
6.8%
1.0%
Q4 24
3.2%
1.0%
Q3 24
5.2%
3.8%
Q2 24
5.8%
2.1%
Cash Conversion
ATEN
ATEN
SDGR
SDGR
Q1 26
0.19×
Q4 25
2.30×
-0.50×
Q3 25
1.87×
Q2 25
2.10×
Q1 25
1.80×
Q4 24
1.40×
Q3 24
1.59×
Q2 24
1.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATEN
ATEN

Products$44.0M59%
Services$31.0M41%

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons